1. Home
  2. Analysis
  3. Antivert
  4. Jantoven

Antivert and Jantoven drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Antivert (meclizine hydrochloride) and Jantoven (warfarin sodium). Common drug interactions include chronic kidney disease among females and international normalised ratio decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Antivert and Jantoven. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Jantoven?

Jantoven has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 1,608 Jantoven users. Check the latest studies of Jantoven.

On Jul, 11, 2026

12 people who take Antivert and Jantoven together, and have interactions are studied.

Antivert and Jantoven drug interactions.

What are the common drug interactions of Antivert and Jantoven, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

male:

  1. International normalised ratio decreased
  2. International normalised ratio increased
  3. Drug ineffective
  4. Drug intolerance (drug sensitivity)
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  6. Peripheral swelling
  7. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Antivert and Jantoven, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

60+:

n/a

What are the existing conditions these people have? *

  1. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 8 people, 66.67%
  2. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 8.33%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 8.33%
  4. Sleep Disorder: 1 person, 8.33%
  5. Oedema (fluid collection in tissue): 1 person, 8.33%
  6. Nausea (feeling of having an urge to vomit): 1 person, 8.33%
  7. Muscle Spasms (muscle contraction): 1 person, 8.33%
  8. High Blood Pressure: 1 person, 8.33%
  9. High Blood Cholesterol: 1 person, 8.33%
  10. Headache (pain in head): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and Jantoven?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Antivert and Jantoven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Jantoven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Jantoven and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride and warfarin sodium (the active ingredients of Antivert and Jantoven, respectively), and Antivert and Jantoven (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.